2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …
E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] T2 mapping in myocardial disease: a comprehensive review
Cardiovascular magnetic resonance (CMR) is considered the gold standard imaging
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
[HTML][HTML] SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance
Abstract The Society for Cardiovascular Magnetic Resonance (SCMR) last published its
comprehensive expert panel report of clinical indications for CMR in 2004. This new …
comprehensive expert panel report of clinical indications for CMR in 2004. This new …
Cardiac sarcoidosis: state-of-the-art review
V Kouranos, R Sharma - Heart, 2021 - heart.bmj.com
Sarcoidosis is a systemic inflammatory disease characterised histologically by the formation
of non-caseating granuloma in multiple organs. 1 The cause of the disease remains …
of non-caseating granuloma in multiple organs. 1 The cause of the disease remains …
[HTML][HTML] Cardiac sarcoidosis: diagnosis and management
E Markatis, A Afthinos, E Antonakis… - Reviews in …, 2020 - imrpress.com
Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …
Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis
Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …
Myocardial fibrosis: why image, how to image and clinical implications
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …
assess cardiac anatomy, function, tissue composition and disease activity across a wide …
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
E Cheung, S Ahmad, M Aitken, R Chan… - European journal of …, 2021 - Springer
Purpose To evaluate the diagnostic and prognostic significance of combined cardiac 18F-
fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected …
fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected …
Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis
A Stevenson, JJH Bray, L Tregidgo, M Ahmad… - Cardiovascular …, 2023 - jacc.org
Background Sarcoidosis is a complex multisystem inflammatory disorder, with approximately
5% of patients having overt cardiac involvement. Patients with cardiac sarcoidosis are at an …
5% of patients having overt cardiac involvement. Patients with cardiac sarcoidosis are at an …